Every 8-K that Caring Brands, Inc. (CABR) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow CABR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CABR filings page.
Caring Brands, Inc. (CABR) disclosed completion of a subsequent closing of its previously announced private placement of Series B Convertible Preferred Stock and warrants, adding $2,549,900 of gross proceeds on September 11, 2026. Together with the initial closing, the PIPE financing totals $7,149,900 of gross proceeds and an estimated $6,999,900 net cash increase after offering costs.
The preferred-stock PIPE and the reclassification of $3,852,686 of Series A preferred from mezzanine equity to permanent equity result in preliminary unaudited pro forma stockholders’ equity of $8,220,419 as of August 31, 2026, compared with Nasdaq’s $2,500,000 equity requirement. Nasdaq and its Hearings Panel must still determine whether equity compliance has been regained, and the company notes that further losses, dividends, or adjustments could reduce equity.
Caring Brands, Inc. (CABR) entered into a Consulting Services Agreement with Myall Luna Ventures Inc., effective September 2, 2026, under which Myall Luna, led by President Brian R. Meadows, will provide financial and accounting management support for cash flow management, financial reporting and other public company services coordinated with the Chief Financial Officer. The agreement runs from September 2, 2026 through September 1, 2027, includes a $10,000 monthly fee payable in advance plus approved expenses, is terminable by either party on 30 days’ written notice, and requires refunds of any unearned prepaid amounts, while the company retains responsibility for management decisions, internal controls and financial statements.
The board appointed Brian R. Meadows as a director effective September 4, 2026 and determined he qualifies as an independent director under Nasdaq Listing Rule 5605(a)(2) after considering the consulting relationship. An Independent Director’s Agreement provides Meadows an annual grant of options to purchase 25,000 shares of common stock at market price, expiring five years after issuance, along with customary confidentiality, non-compete, expense reimbursement, indemnification, and insurance provisions.
Caring Brands, Inc. (CABR) reported that it has begun accessing capital under a $9 million Purchase Agreement through a private placement. On September 1, 2026, the company completed an initial closing, issuing convertible preferred shares to accredited investors for $4.6 million. As of the press release date, an additional $4.4 million of subscription documents had been executed, with the company expecting, subject to closing conditions, to issue 4,400 shares of Series B Preferred Stock plus Series A and Series B Warrants covering up to 8,800,000 common shares when funds clear, which it expects on or before September 4, 2026. The company plans to use initial proceeds to launch new salesforce and marketing campaigns. Caring Brands describes a portfolio of patented, clinically validated skin and hair products, with current revenues from Hair Enzyme Booster and Photocil and a pipeline including CB-101 for eczema and NoStingz sunscreen.
Caring Brands, Inc. (symbol: CABR) is the issuer of record for a Form 8-K filing submitted to the SEC.
Caring Brands, Inc. (CABR) entered into a private placement Securities Purchase Agreement with accredited investors to raise up to $11,000,000 through the sale of up to 11,000 shares of newly designated Series B Convertible Preferred Stock at $1,000 per share and related warrants. Investors receive Series B Preferred Stock convertible into common stock at an initial price of $0.70 per share, plus Series A Warrants to purchase up to 11,000,000 common shares at $0.825 and Series B Warrants to purchase up to 11,000,000 common shares at $0.95, all subject to a 4.99%/9.99% beneficial ownership limitation and a 19.99% Nasdaq Exchange Cap unless stockholders approve more shares. The Series B Preferred Stock bears an 8% annual dividend and ranks pari passu with the company’s Series A Preferred Stock on liquidation. Caring Brands agreed not to use variable rate or similar equity financing while these securities remain outstanding and granted investors registration rights, with liquidated damages of 1.0% per month of each investor’s purchase amount (capped at 6.0%) if registration deadlines are missed. The company also amended its Series A Preferred Stock designation, including increasing authorized Series A shares to 4,500 and aligning certain terms with the new Series B.
Caring Brands, Inc. reported an update on its intellectual property portfolio, which now includes five issued U.S. patents covering its Hair Enzyme Booster and Photocil product platforms. Four patents relate to Hair Enzyme Booster and one to Photocil.
Hair Enzyme Booster targets a $1.8B+ hair-loss market opportunity, with patents covering compositions and methods involving sulfotransferase enzyme activity and minoxidil metabolism. The company notes that 50% to 60% of minoxidil users may not see optimal results due to low scalp enzyme levels, and the product is designed for use alongside topical minoxidil to improve response.
Photocil, protected by an issued U.S. patent, addresses a $20B+ dermatology market opportunity as a topical narrow-band UV filter for targeted skin health, including over 125 million psoriasis and 100 million vitiligo sufferers globally. Caring Brands emphasizes a licensing-led, multi-channel commercialization strategy, including partnerships with companies such as Taisho Pharmaceutical, continued patent prosecution in the U.S. and abroad, and B2B licensing supplemented by direct-to-consumer sales.
Caring Brands, Inc. reports that Nasdaq’s Listing Qualifications Staff issued a Staff Delisting Determination after the company failed to meet Nasdaq Listing Rule 5550(b). The company had stockholders’ equity of $2,091,324, below the required $2.5 million, and did not meet the alternative continued listing standards for market value or net income.
The Determination denies the company’s request for continued listing. Unless a hearing is requested by 4:00 p.m. ET on July 22, 2026, trading in its common stock will be suspended at the opening on July 24, 2026 and Nasdaq will file a Form 25-NSE. Caring Brands intends to request a hearing and pay the applicable fee by July 21, 2026, which would stay any suspension pending a Panel decision, but there is no assurance the company will regain or maintain compliance.
Caring Brands, Inc. entered into a private investment in public equity on July 10, 2026, selling 443.2133 shares of Series A Convertible Preferred Stock with a stated value of $1,000 per share at $950 per share and issuing 1,052,632 common stock warrants at a $0.40 exercise price.
The transaction generated $400,000 in gross proceeds; $150,000 will be used to retire 150,000 common shares from BK Investments LLC, with the remainder for general corporate and working capital purposes. An amendment increased authorized Series A Preferred shares to 4,500 and set an 8% dividend, while warrant exercises and conversions are limited by a 4.99% beneficial ownership cap and a 19.99% issuance cap without shareholder approval.
Caring Brands, Inc. held a Special Meeting of Stockholders on July 9, 2026. As of the May 14, 2026 record date, there were 9,091,506 shares of common stock outstanding and entitled to vote. Holders of 5,617,697 shares, representing approximately 61.79% of eligible shares, were present in person or by proxy, constituting a quorum.
Stockholders approved three proposals. The Additional Investment Right Proposal received 4,457,375 votes for, 155,999 against and 1,000 abstentions, with 1,003,323 broker non-votes. The Share Issuance Proposal received 4,456,776 for, 156,598 against and 1,000 abstentions, with 1,003,323 broker non-votes. The Increase in the Number of Authorized Shares of Common Stock Proposal received 5,118,645 for, 498,052 against and 1,000 abstentions, with no broker non-votes. No other substantive matters were voted on.
Caring Brands Inc. entered into an expanded multi-territory licensing agreement with SanPellegrino Cosmetics Private Limited for its Photocil and Hair Enzyme Booster products. The revised agreement, effective May 21, 2026, introduces a five-year initial term with automatic annual renewal.
The deal broadens SCPL’s licensed territory beyond India to include multiple LATAM countries, Russia, Australia and New Zealand, leveraging existing sublicense partnerships with Eris Lifesciences and Glenmark Pharmaceuticals. Caring Brands highlights that this expansion supports its strategy to grow revenue from patented, clinically validated skin and hair-growth products across high-growth international markets.
Caring Brands, Inc. filed a current report to correct an administrative error in its proxy materials. The company’s Definitive Proxy Statement for its annual meeting had incorrectly listed May 12, 2026 as the record date. The correct record date for determining stockholders entitled to receive notice of, and vote at, the annual meeting is May 14, 2026.
All other information in the original proxy statement remains unchanged, and only stockholders of record as of May 14, 2026 will be eligible to participate in the meeting. The company plans to file a revised definitive proxy statement reflecting this corrected date.
Caring Brands, Inc. received a Nasdaq Staff Delisting Determination after falling out of compliance with Nasdaq Listing Rule 5550(b)(1), which requires at least $2.5 million in stockholders’ equity. The company’s latest Form 10-K reported stockholders’ equity of $2,091,324, triggering the notice.
Caring Brands has 45 days, until May 22, 2026, to submit a plan to regain compliance and could receive up to 180 days, until October 4, 2026, to demonstrate compliance if Nasdaq accepts the plan. The notice does not immediately affect trading, and the stock continues to trade on Nasdaq under the symbol CABR, but failure to regain compliance could lead to delisting.
Caring Brands, Inc. reported two governance changes. The Board amended the company’s bylaws so that stockholders holding thirty-three and one-third percent (33 1/3%) of outstanding capital stock entitled to vote now constitute a quorum for stockholder meetings, instead of a majority. The Board also appointed founder and Chairman Brian John, age 56, to serve as Interim Chief Financial Officer and to act as principal financial officer and principal accounting officer, effective March 30, 2026. As of this filing, his existing compensation arrangements remain unchanged in connection with this interim appointment.
Caring Brands, Inc. entered into a $3.6 million private investment in public equity, issuing 3,789.74 shares of Series A Convertible Preferred Stock at $950 per share with a stated value of $1,000 and an 8% dividend. The preferred stock is convertible into common shares at $0.40 and is paired with 9,473,685 common warrants, also exercisable at $0.40 for five years, all subject to beneficial ownership limits and a 19.99% cap without shareholder approval.
The company plans to use $3.075 million of the proceeds to repurchase 6,250,000 common shares from insiders, reducing common shares outstanding from 14,761,925 to 8,511,925, with the balance for general corporate and working capital needs. The investor also obtained an option to invest up to an additional $4.0 million on similar terms and received a 12‑month right of first refusal on future financings, while the company agreed to register the resale of the underlying shares.
Caring Brands, Inc. reported that it has been issued two new United States patents. These patents cover proprietary methods and compositions that enhance enzymatic activity in hair follicles. Management explains that this intellectual property further strengthens protection around its Hair Enzyme Booster product and related technologies, potentially reinforcing its competitive position in hair-focused treatments.
Caring Brands, Inc. reported that its Chief Financial Officer, Tyler Moore, resigned from his position effective after notifying the company on January 5, 2026. The company states that his resignation was not due to any disagreement regarding its operations, policies, or practices, which signals this is characterized as an orderly leadership change rather than a dispute.
Caring Brands has begun a search to identify a new Chief Financial Officer and expects to appoint a successor in the near term. Until a replacement is named, the company plans to handle its financial and reporting responsibilities through its existing management team, indicating continuity of core finance functions during the transition.